This report will incorporate an analysis of Blackmores LTD including, the level of leverage and the companys capital structure; the dividend policy and the amount of dividends paid to the shareholder; and finally, a valuation analysis on Blackmore

Authors Avatar

Table of Contents

1        introduction        

2                

3        Corporation Background        

3.1        Organization        

3.2        Market Position        

3.3        Government Impact        

3.4        Description of Competitors        

4        Capital Structure        

4.1        Blackmores’ Current & Historical Leverage        

4.1.1        Debt to Equity Ratio        

4.1.2        Degree of Financial Leverage and Operating Leverage        

4.2        Capital Expenditure and Financing        

4.3        Capital Structure Relative to Competitors        

4.4        Bankruptcy Risk Assessment        

4.5        Leverage Policy Summary        

4.6        Is this the Optimal Leverage Policy?        

5        Dividend Policy        

5.1        Current and Recent History of Dividend Payment        

5.2        Dividend policy comparing to comparable firms        

5.3        Relevant Company Characteristics to its Dividend Policy        

5.4        Analysis of Company’s Dividend Policy and Lintner’s Analysis        

5.5        Optimal Dividend Policy        

6        Valuation        

6.1        Assumptions        

6.2        Valuation Method        

6.2.1        Determining the Cost of Equity (rS)        

6.2.2        Determining the Cost of Debt (rb)        

6.2.3        Weighted Average Cost of Capital (WACC)        

6.2.4        Estimating the Future Sales Growth Rate        

6.2.5        Estimating Future Cash Flows        

6.2.6        Estimating Firm value        

6.3        Sensitivity Analysis        

6.3.1        Share price sensitivity to changes in the Sales Growth Rate (2011-2020)        

6.3.2        Share Price Sensitivity to Change in the Sales Growth Rate (after 2020)        

6.3.3        Share Price Sensitivity to Changes in WACC        

6.4        Comparison of the Estimated and Actual Share Price        

7        Investment Recommendation        

8        Appendix        

9        Reference        


  1. Executive Summary

Blackmores LTD (BKL) which started in the 1930s is a major player in developing and marketing products and services that deliver a more natural approach to health, based on their expertise in vitamins, minerals, herbs and nutrients.

   

For the year ended 30 June 2010, Blackmores posted a net profit after tax of $24.3 million, an increase of 17% on last year. Group revenue increased by 7% to $214.9 million; earnings before interest, tax, depreciation and amortization (EBITDA) increased by 25%; and earnings per share increased by 15%.

This report will incorporate an analysis of Blackmores LTD including, the level of leverage and the company’s capital structure; the dividend policy and the amount of dividends paid to the shareholder; and finally, a valuation analysis on Blackmores based on WACC.


  1. Introduction

The purpose of this paper is to analyze the Corporate Finance of Blackmores. The analysis will contain three main components of capital structure, dividend policy and valuation analysis.

Blackmores is a multinational organization operating in Australia, New Zealand and Asia and currently employs more than 500 people in the region. The company has a multibillion dollar market capital in the area of developing and marketing branded vitamins and supplements.

The analysis Blackmores in this report include:

  • Capital structure and leverage policy
  • Operational and financial leverage
  • Capital expenditure, financing and structure
  • Assessment of bankruptcy risk and cost
  • Dividend Policy
  • Current and past five years dividend policy and franking credits
  • Company dividend policy and the peer group comparison
  • Characteristics and an analysis of the company’s dividend policy
  • Consistency with Linter’s analysis
  • Analysis of whether the SHL dividend policy is optimal
  • Company valuation and share price
  • Blackmores share price estimation using Weighted Average Cost of Capital and Net Present Value
  • Valuation assumption and related explanations
  • Company Beta value estimation
  • Share price comparison and difference analysis
  • Valuation sensitivity analysis

  1. Corporation Background

  1. Organization

Blackmores LTD (BKL) which started in the 1930s is a major player in developing and marketing products and services that deliver a more natural approach to health, based on their expertise in vitamins, minerals, herbs and nutrients.

Blackmores’ first public issue was on 2nd May 1985, and the organization is presently listed on the Australian Stock Exchange (ASX) with a market cap of $501 million (11/05/2011). The organization currently employs over 500 staff in Australia, New Zealand and Asia.

Blackmores principal activities include

  • Products:  BKL has a growing range of products that cater for areas in natural health including: Arthritis; Joint, Bone and Muscle; Brain Health; Children's Health; Cold, Flu and Immunity; Digestive Health; Energy; Everyday Health; Eye Health; Heart and Circulation; Men's Health; Nails, Hair and Skin; Nutritional Oils; Stress Relief; Teen Health; Weight Management and; Women's Health.
  • Services:  A team of health experts are on hand to provide advice on natural healthcare, research findings, issues, news and information on products.
  • International Operations:  Products are distributed in New Zealand, Malaysia, Thailand, Taiwan, Singapore and Hong Kong.
  1. Market Position

Through the examination of BKL in the past several years, the effect of the Global Financial Crisis is evident; however the senior level managers still indicated a positive attitude towards the development of BKL.

The 2010 annual report pointed that, for the year ended 30 June 2010, BKL posted a net profit after tax of $24.3 million, an increase of 17% comparing to last year. In addition, Group revenue increased by 7% to $214.9 million; earnings before interest, tax, depreciation and amortization (EBITDA) increased by 25%; and earnings per share increased by 15%.

These results were significantly higher than BKL’s expectations and slightly ahead of BKL’s revised profit expectations. This was achieved despite the fall in retail growth in Australia, the political uncertainty in Thailand, the impact of the strong Australian dollar on our Asian sales, and the absence of major health concerns such as H1N1.

What should be emphasized are two points: BKL’s profitability grew faster than their sales, and EBITDA increased significantly in a year of increased investment.

  1. Government Impact

Blackmores’ products are developed using a combination of traditional knowledge and scientific evidence. Its product formulations are approved by regulatory bodies where they are sold and are required to meet both local and various governments’ stringent standards of safety, efficiency and quality. Moreover, it uses high quality ingredients sourced from all over the world and its products are made to exact requirements, under the international PIC/s (Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme) standards of good manufacturing practice.

The company remains very actively engaged with the regulator and with the Government to ensure that the operating environment continues to allow it to effectively grow its businesses and market its products. It has established a very good relationship with the Government and with the Opposition – and it continues to educate them about the benefits of complementary medicines.

Blackmores ranked fifth in terms of the most positive sentiment based on a review of more than a million news articles and official ASX announcements published throughout the year 2009. The Company monitors its legal obligations and has its own self-imposed policies. The Directors believe that the Company complies with all aspects of the environmental laws. The Company is a party to the National Packaging Covenant, an agreement between the industry and government which ensures that the management of packaging and paper produces cost-effective, sustainable benefits to the environment throughout their lifecycle.

  1. Description of Competitors

As the primary activities of Blackmores LTD, in health supplements, are in a specialized area of the health sector, the direct competitors are not publicly listed on the ASX. These competitors include, Bullivant, Nature’s Way, Cenovis and Golden Circle. For the report and more specifically the comparative analysis of Blackmores, the following companies were chosen.

Vita Life Sciences LTD (VSC): is mainly involved with the development and distribution of, complementary and alternative medicines; dietary supplements; and health foods. The products that are developed and distributed from Vita Life Sciences are aligned with that of Blackmores and present a good analytical comparison. However VSC was recently publicly listed, on the 23rd August 2007, therefore having volatile earnings and having a small market capitalization. Vita Life Sciences was used for comparison as it presents a listed company that is most similar to Blackmores’ activities.

Join now!

Australian Pharmaceutical Industries LTD (API): The primary activities of the company compromises of a wide range of areas including, retail operation; finance origination and retail services to pharmacists; distribution of pharmaceutical and medical consumable products to hospitals; and manufacture and distribution of pharmaceutical medicines and consumer toiletries. Even though these activities do not directly reflect that of Blackmores, API has fairly stable, long term earnings in the healthcare sector, for comparison.

Sigma Pharmaceutical LTD (SIP): Even though Sigma does not directly deal with vitamins and health supplements the company is similar to BKL as it is concerned with the manufacturing, development and ...

This is a preview of the whole essay